In this Issue
A look at how advances in stent therapy will supplant the current standard.
CHIEF MEDICAL EDITOR'S PAGE
By Ted E. Feldman, MD, FSCAI - Chief Medical Editor
A new approach to an old problem.
By Jason H. Rogers, MD
How to facilitate expansion of a severely underexpanded stent.
By David J. James, md; S. Chiu Wong, MD; and Issam D. Moussa, MD
Goals for stent, polymer, and drug development.
By Tim A. Fischell, MD, FACC, FSCAI; Dwight Dishmon, MD; Adam Elhaddi, MD; Shadwan Alsafwah, MD; and Santhosh R. Mannem, MD
Current data on the use of drug-eluting balloon angioplasty to treat atherosclerotic arterial disease are limited but hold promise.
By Verghese Mathew, MD, FACC
An overview of polymer technology as a drug-carrier mechanism.
By Wei Fan; Dave M. Johnson, Phd; and Marc D. Feldman, MD, FACC
A review of the breakthroughs and challenges of bioabsorbable stents as a potential solution to the risks associated with available drug-eluting stents.
By Refat Jabara, MD, FACC; Lakshmana Pendyala, MD; Jack Chen, MD, FACC; and Nicolas Chronos, MD, FACC
FEATURED TECHNOLOGYSponsored by Cardiogenesis
By Geoffrey Answini, MD, and Averel Snyder, MD
Dr. Satler discusses his facility at the Washington Cardiology Center and their role in ushering in new treatments, devices, and education, specifically for treating structural heart disease.